All Stories

  1. Cytosolic phosphoenolpyruvate carboxykinase is expressed in α‐cells from human and murine pancreas
  2. Gluconeogenic Enzymes in β-Cells: Pharmacological Targets for Improving Insulin Secretion
  3. Sodium tungstate: Is it a safe option for a chronic disease setting, such as diabetes?
  4. The Antidiabetic Agent Sodium Tungstate Induces Abnormal Glycogen Accumulation in Renal Proximal Tubules from Diabetic IRS2-Knockout Mice
  5. SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies
  6. Aging Selectively Modulates Vitamin C Transporter Expression Patterns in the Kidney
  7. Sodium tungstate mimics insulin effect on nuclear translocation of FBPase in rat liver
  8. Apical Polarization of SVCT2 in Apical Radial Glial Cells and Progenitors During Brain Development
  9. Is the anti-diabetic agent sodium tungstate an anti-inflammatory factor?
  10. SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?
  11. SVCT2 Overexpression in Neuroblastoma Cells Induces Cellular Branching that is Associated with ERK Signaling
  12. In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line
  13. Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans
  14. Over-expression of muscle glycogen synthase in human diabetic nephropathy
  15. Fructose 1,6-bisphosphatase and aldolase B location in organs of sheep supplemented with nonprotein nitrogen
  16. Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney
  17. Non-protein nitrogen supplementation increases gluconeogenic capacity in sheep
  18. Dynamic expression of the sodium-vitamin C co-transporters, SVCT1 and SVCT2, during perinatal kidney development
  19. Nuclear accumulation of fructose 1,6-bisphosphatase is impaired in diabetic rat liver
  20. Expression of key substrate cycle enzymes in rat spermatogenic cells: Fructose 1,6 bisphosphatase and 6 phosphofructose 1-kinase
  21. Novel expression of liver FBPase in Langerhans islets of human and rat pancreas
  22. Subcellular localization of liver FBPase is modulated by metabolic conditions
  23. Different involvement for aldolase isoenzymes in kidney glucose metabolism: Aldolase B but not aldolase A colocalizes and forms a complex with FBPase
  24. Nuclear localization of liver FBPase isoenzyme in kidney and liver
  25. Broad expression of fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney